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Abstract
Protein Quality Control (PQC) pathways are essential to maintain the equilibrium between protein folding and the clearance
of misfolded proteins. In order to discover novel human PQC factors, we developed a high-content, high-throughput cell-
based assay to assess PQC activity. The assay is based on a fluorescently tagged, temperature sensitive PQC substrate and
measures its degradation relative to a temperature insensitive internal control. In a targeted screen of 1591 siRNA genes
involved in the Ubiquitin-Proteasome System (UPS) we identified 25 of the 33 genes encoding for 26S proteasome subunits
and discovered several novel PQC factors. An unbiased genome-wide siRNA screen revealed the protein translation
machinery, and in particular the EIF3 translation initiation complex, as a novel key modulator of misfolded protein stability.
These results represent a comprehensive unbiased survey of human PQC components and establish an experimental tool
for the discovery of genes that are required for the degradation of misfolded proteins under conditions of proteotoxic
stress.
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Introduction
Cellular proteins must assume and maintain their native 3D
conformation in order to be functionally active. Partial folding or
misfolding renders proteins non-functional, and improperly folded
proteins may become toxic to the cell [1,2]. Accurate folding of
proteins is particularly critical to prevent the formation of cellular
aggregates and is implicated in human disease. Misfolded proteins
tend to expose highly hydrophobic surfaces that are normally
buried in their interior. Given the hydrophilic nature of the
cellular medium, hydrophobic surfaces from different misfolded
proteins tend to interact with each other and to form cellular
aggregates [1]. Protein misfolding can lead to the disruption of
protein homeostasis in a dominant negative fashion and may
ultimately cause cell death as seen in Parkinson, Alzheimer and
Huntington disease [3,4].
Cells possess dedicated Protein Quality Control (PQC)
pathways to ensure maintenance of the proteostatic equilibrium
[3]. One arm of the PQC systems consists of protein chaperones
that bind to unfolded proteins, including newly synthesized
proteins, and, by hydrolysing ATP, actively aid in attaining
mature protein conformation [1,5]. The PQC system also acts on
mature, properly folded but metastable proteins that have a
tendency to revert to a non-native state, particularly in conditions
of proteotoxic stress such as in the presence of oxidizing agents or
elevated temperature [5]. A second arm of the PQC system clears
proteins damaged beyond repair [6]. This pathway includes E1-,
E2- and E3-ubiquitin ligases, which are recruited by the
chaperones themselves and poly-ubiquitinate irreversibly mis-
folded proteins, thus targeting them for proteolysis by the 26S
proteasome. Finally, a multitude of dedicated transcription factors
responds to proteotoxic stimuli by up-regulating the transcription
of genes that promote PQC [7,8].
The PQC pathways are spatially compartmentalized according
to the subcellular location of their misfolded substrates. Specific
pathways dealing with misfolded proteins exist in the cytoplasm, in
the ER and in mitochondria [8–11]. Previous work in S. cerevisiae
also suggests that the nucleus contains E3-ubiquitin ligases
dedicated to PQC [12–14]. In support, there is evidence that
some misfolded substrates are also degraded in the mammalian
nucleus [15,16].
Alterations to protein homeostasis, either due to an increase in
the load of misfolded proteins or due to a failure of the PQC
systems to respond to proteotoxic stress, underlie common human
neurological diseases, aging and cancer [5,17]. Hence, the
discovery and characterization of novel genes that belong either
to the PQC pathways, or that regulate PQC activity upon external
cues, is of great basic and applied importance. Expression of
pathologically misfolded proteins in small model organisms such as
S. cerevisiae,C .elegans and D. melanogaster has been used in reverse
genetic screens to identify cellular modifiers of protein misfolding
and aggregation [18–21]. However, no cellular assays for the
systematic and unbiased discovery, for example by RNAi
screening, of PQC factors in mammalian cells have been reported.
Given the lack of tools to study PQC systems in mammalian cells
in an unbiased fashion, we designed and implemented a cell-based
assay to measure the degradation of a misfolded protein in intact
cells. Here we describe a quantitative, high-content fluorescence
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and we use it in a targeted siRNA screen of 1591 genes belonging
to the Ubiquitin Proteasome Systems (UPS) and in a genome-wide
unbiased global screen. We identify several novel players in the
human PQC pathway.
Results
Assay Design
We set out to identify novel human genes involved in PQC in
the cell nucleus in an unbiased fashion using a cell-based assay. In
order to measure the activity of the PQC pathways in the cell
nucleus in living cells, we took advantage of a temperature-
sensitive (ts) allele of the nuclear localized SV40 virus Large T
antigen (LTag(ts)) [22]. SV40-LTag(ts) is stable at the permissive
temperature of 33.5uC but becomes unstable and is rapidly
degraded at the non-permissive temperature of 38.5uC (Figure
S1A). We chose SV40-LTag because it represents a class of long-
lived nuclear proteins representative of many chromatin associated
proteins, transcription factors and nuclear lamins whose degrada-
tion is only poorly characterized. In order to use the LTag(ts) PQC
probe in high-throughput, quantitative fluorescence microscopy
experiments we created a stable cell line containing a recombinant
LTag(ts) protein fused in frame to EGFP (Figure 1A). In addition,
we placed a red fluorescent protein fused to a nuclear localization
signal (NLS-DsRedExpress2) downstream of an internal ribosome
entry site (IRES) (Figure 1A). This arrangement guarantees that
both open reading frames encoding the fluorescent proteins are
co-cistronically transcribed and translated at a constant ratio.
Degradation of LTag(ts)-EGFP can be measured as a change in
the ratio between nuclear green and red fluorescence signals
(Figure 1A). The generation of LTag(ts)-EGFP and NLS-
DsRedExpress2 from the same RNA rules out changes due to
transcriptional or translational effects and the presence of the
NLS-DsRedExpress2 protein allows internal normalization of
sample-to-sample fluorescence intensity fluctuations in high-
throughput screening formats [23].
As expected, steady-state levels of LTag(ts)-EGFP stably
expressed in U2OS cells were stable at the permissive temperature
(33.5uC), but declined 24 hrs after the switch from the permissive
to the restrictive temperature as determined by Western Blotting
(38.5uC, Figure 1B). Degradation was specific to the temperature
sensitive LTag mutant, since LTag(WT)-EGFP levels remained
unchanged, thus ruling out possible transcriptional or translational
effects due to the elevated temperature (Figure 1B). Furthermore,
treatment with the proteasome inhibitor MG132 completely
blocked the reduction of LTag(ts)-EGFP at the restrictive
temperature (Figure 1C). The degradation properties of the
LTag(ts) fusion protein were not due to the presence of the EGFP
tag, since the kinetics of degradation of the EGFP-tagged version
of LTag(ts) and LTag(WT) and the sensitivity of LTag(ts)-EGFP
degradation were identical to their untagged counterparts (Figure
S1A and S1B). These results indicate that at the restrictive
temperature LTag(ts)-EGFP, but not LTag(WT)-EGFP, engages
the cellular PQC pathways leading to its degradation, making it a
suitable reporter for the identification of novel PQC components.
Having biochemically demonstrated the feasibility of using
LTag(ts)-EGFP as a probe to measure PQC in human cells, we
tested its usefulness as a reporter in a high-content fluorescence
microscopy format. Both LTag(ts)-EGFP and NLS-DsRedEx-
press2 localized to the nucleus at the permissive temperature
(Figure 2A and 2B, 33.5uC). When cells were shifted to the
restrictive temperature for 24 h the LTag(ts)-EGFP signal was
reduced with no apparent change in the NLS-DsRedExpress2
signal (Figure 2A and 2B, 38.5uC). The qualitative reduction of
LTag(ts)-EGFP was confirmed quantitatively. The average
LTag(ts)-EGFP intensity was typically reduced by about 66%
after 24 h at the restrictive temperature (Figure 2B and 2E), and as
a consequence the EGFP/DsRedExpress2 ratio was reduced by
,50% (Figure 2B and 2E). Single cell analysis confirmed that,
upon shift from 33.5uC to 38.5uC, and for the entire population of
LTag(ts)-EGFP expressing cells, but not for LTag(WT)-EGFP
expressing cells, the distribution of the EGFP/DsRedExpress2
ratio shifted toward lower values (Figure S1C).
The reduction in the LTag(ts)-EGFP signal was due to protein
degradation since proteasome inhibition with MG132 at the
restrictive temperature resulted in a complete rescue of the mean
nuclear green fluorescence intensity and of the EGFP/DsRedEx-
press2 ratio, with no major alteration in the mean nuclear red
fluorescence intensity (Figure 2C and 2E). Furthermore, the
observed degradation was specific to the ts-mutant since no loss of
EGFP signal was observed when cells expressing LTag(WT)-
EGFP and NLS-DsRedExpress2 were shifted to the restrictive
temperature (Figure 2D). These results are in line with the
biochemical data (Figure 1) and demonstrate that the EGFP/
DsRedExpress2 ratio is an accurate and quantitative indicator of
PQC activity in the nucleus of human cells.
A targeted high-throughput RNAi screen for PQC
components
In order to identify novel genes of the PQC pathway, we
initially used the LTag(ts)-EGFP/NLS-DsRedExpress2 cell line to
screen a library containing 991 pools of 4 siRNA oligos targeting
human genes involved in the Ubiquitin Proteasome System (UPS)
(Table S1). The screen was conducted in triplicate in a 384-well
format by reverse-transfecting cells with siRNA pools for 48 h at
33.5uC, followed by a shift to 38.5uC for another 24 h before
fixation of cells in paraformaldehyde (See Materials and Methods).
We imaged 12 fields per well at 406magnification in 3 channels
in an automated fashion (green, red and far red to detect the DNA
stain DRAQ5) for a total of 300–600 cells per RNAi pool. Z9-
scores for the EGFP/DsRedExpress2 ratio were calculated using
positive (MG132, 250 nM) and negative (non-targeting siRNA
pool) controls for each replicate and they ranged from 0.5 to 0.74
(See Materials and Methods). Samples treated with the positive
control MG132 had Z-scores ranging from 17.81 to 24.01
(Figure 3A). Of the 991 siRNA pools 57 had a statistically
significant effect on the EGFP/DsRedExpress2 ratio correspond-
ing to a hit-rate of 5.7%. Positive hits had EGFP/DsRedExpress2
Z-scores between 2 and 17.72 (Figure 3A and Table S2). Among
the hits were 3 out of the 4 genes encoding ubiquitin in the human
genome (UBB, UBC and RPS27A), the 20S proteasome chaperone
C13ORF12 (Table S2 and Figure 3B) and 2 genes encoding the
ubiquitin-like proteins FAU and SUMO1 (Table S2). In addition,
we also identified 25 out of the 33 genes encoding the 26S
proteasome core subunits [24], including PSMD8, one of the 9
subunits of the 19S proteasome lid (Figure 3B and Table S2).
Silencing of DSCR2/PAC1, another 20S proteasome chaperone
involved in the same pathway as C13ORF12, did not cause an
increase in either LTag(ts)-EGFP fluorescence (Figure 3B) or in the
EGFP/DsRedExpress2 ratio (Table S2). These results indicate
that the PQC assay is capable of capturing many of the genes
whose silencing results in an inhibition of the degradation of
misfolded proteins.
Given the prominent role of 26S proteasome and ubiquitin
genes in our list of primary hits, we further used the PQC cell line
to screen a library containing 600 siRNA pools targeting the
expression of all predicted E1-, E2- and E3-ubiquitin ligases in the
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(EGFP/DsRedExpress2 Z-score.2), we identified 13 primary hits
from this library (Table S4), among them UBE2D3, one of the 4
human genes encoding for a protein orthologous to the Ubc4/5
E2 ubiquitin ligase, which was previously shown to participate in
the ubiquitination of misfolded proteins in S. cerevisiae [25]. As
expected, silencing of the proteasome subunits lead to varying
cytotoxic effects (Z-scores ranging from 6.08 for PSMD1 to 1.34 for
PSMD13, equivalent to 33% to 85.3% viability, respectively), as
measured by the number of cells present at the end of the
experiment, when compared to the median number of cells
transfected with the UPS siRNA library (Table S5). On the other
hand, under the same conditions silencing of POMP had only a
minimal effect on cell viability (Z-score of 1.89, equivalent to
79.4% viability) (Table S5).
Validation of primary hits
To rule out the possibility that the observed biological activity of
the siRNA pools was due to non-specific off-target effects, we
assembled a validation library of 48 siRNA pools with a modified
chemical backbone distinct from that used in the primary screen
(See Materials and Methods). This validation library contained
most of the primary hits obtained from the UPS and the Ubi123
screens. 5 of the 25 26S proteasome genes were also included as
controls (Table S6). Amongst the 48 selected genes (Z-Score.2i n
primary screen), 11 also reached a Z-score of .2 when validated
against the LTag(ts)-EGFP cell line at 38.5uC. Importantly, 8 out
of the top 10 primary screen hits (Z-Score.4) reproduced in this
validation experiment (Z-Score.2, Figure 3C, and Table S2 and
S4). These results indicate a false positive discovery rate of ,20%,
which is comparable to screens using the same siRNA reagents
[26]. We conclude that the identified genes are bona fide
components of the PQC machinery.
Identification of constitutive protein degradation
components vs. PQC components
In order to distinguish genes that play a constitutive role in
protein degradation from genes specifically involved in PQC of
misfolded proteins, we counter-screened cell lines expressing either
LTag(WT)-EGFP or LTag(ts)-EGFP at both 33.5uC and 38.5uC.
A gene preferentially involved in the degradation of misfolded
proteins should show activity in the PQC screen in the cell line
expressing the ts and not the WT version of the LTag, and it
should do so specifically at the restrictive but not the permissive
temperature. By ranking the siRNA pools in the validation library
according to their DZ-score at either temperature (defined as the
difference of the Green/Red Z-score of the ts protein minus the Z-
score of the WT protein), we identified siRNA pools that had a
high DZ-score at both permissive and restrictive temperature.
These represent constitutive components of the Ubiquitin-Protea-
some System. As expected, siRNA pools targeting genes encoding
core members of the protein degradation machinery, such as 26S
proteasome subunits (PSMD8 and PSMA7) or ubiquitin (UBC and
RPS27A), had a significant DZ-score at both temperatures
(Figure 4A). On the other hand, C13ORF12, also known as
hUMP1 or POMP, showed a high DZ-score only at the restrictive
but not at the permissive temperature, thus fitting the require-
ments for a genuine PQC factor (Figure 4A). Furthermore,
silencing of POMP at 38.5uC did not cause an increase in
cytotoxicity when compared to silencing at 33.5uC (94.3% and
87.9% viability, respectively, Table S7). This observation indicates
that the differential effect of silencing POMP expression on the
stability of misfolded proteins at the two temperatures is not
artifactually due to an increase in cytotoxicity.
POMP as a novel target for differential inhibition of
proteolytic activity during proteotoxic stress
POMP encodes a protein chaperone whose role is to promote the
assembly of the 20S proteasome [27–30]. In mammalian cells,
POMP localizes to both the nucleus and the cytoplasmic face of the
ER [31,32]. In human cells POMP binds to proteasome subunits
and facilitates their assembly into the hemi-proteasome, an
intermediate in the mature 20S proteasome formation process that
is formed by two heptameric rings of a- and b- subunits
[24,28,29,33]. Upon completion of this process, two assembled
hemi-proteasomes come together to form the mature 20S protea-
some and POMP is rapidly degraded in the process [27,28]. Other
proteasome chaperones involved in the same pathway, including
DSCR2/PAC1, PAC2, PAC3 and PAC4, were present in the UPS
library used in the primary screen but were not identified as positive
hits. The observed biological effect of was not due to off-target
activity since three out of four independent siRNA oligos present in
the original pool against POMP effectively knocked-down POMP
mRNA transcript levels at both the permissive and at the restrictive
temperature (Figure 4B). 2 out of the 3 effective siRNAs against
POMP showed significant inhibition of LTag-EGFP degradation of
the ts allele but not the WT allele and only at the restrictive
temperature, confirming its role as a novel component in the
proteolytic stress response (Figure 4C). The subcellular localization
of POMP was not altered upon heat-shock at 42.0uC in U2OS cells
(Figure S1D). Given the partial cytoplasmic localization of POMP
inimmunofluorescenceexperiments,wecannotruleoutthatasmall
fraction of LTag may be degraded in the cytoplasm in a POMP-
mediated manner. POMP was not transcriptionally up-regulated at
38.5uC when compared to 33.5uC in LTag(ts)-EGFP expressing
cells (Figure 4B). These results demonstrate a function for POMP in
the degradation of a misfolded substrate in the presence of an
increased proteolytic load and proteotoxic stress conditions. The
finding that, contrary to other genes encoding proteasome subunits
such as PSMD8 or PSMB1, silencing of the POMP gene specifically
inhibited the degradation of LTag(ts)-EGFP at the restrictive
temperature, raises the intriguing possibility that POMP activity
plays a key role in response to proteotoxic stress.
Genome-wide siRNA screen for the identification of PQC
factors
In order to discover additional cellular pathways that affect the
stability of misfolded proteins, we performed an unbiased genome-
wide RNAi screen. We screened a library of ,18, 000 pools of 4
siRNAs targeting most of the annotated human genes against the
LTag(ts)-EGFP/NLS-DsRedExpress2 cell line at 38.5uC. We
identified 84 genes that concomitantly exhibited an EGFP/
Figure 1. A temperature sensitive (ts) allele of the SV40 Large T antigen (LTag) fused to EGFP engages the PQC machinery. a) Outline
of the fluorescent PQC reporter system in mammalian cells. LTR: Retroviral Long Terminal Repeat, CMV: immediate early cytomegalovirus promoter,
LTag; SV40 Large T antigen, ts: temperature sensitive, IRES: internal ribosome entry site, NLS: nuclear localization signal. b) U2OS cells stably
expressing either a wild-type (WT) or a temperature-sensitive (ts) allele of LTag fused to EGFP were grown at 33.5uC and then shifted to 38.5uC for the
indicated amount of time. Total cell lysates were probed in Western Blotting with the indicated antibodies. c) Same as b), except that cells were either
treated with DMSO or the proteasome inhibitor MG132 at a final concentration of 2 mM.
doi:10.1371/journal.pone.0031684.g001
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viability .60% of the population median (Figure 5A and Table
S8), representing a hit rate of ,0.5%. As previously observed for
the UPS-focused siRNA screen, the proteasome subunits genes
PSMD1 and PSMC4 and the ubiquitin gene UBC scored positive,
confirming the specificity of the PQC assay. Gene GO Process
Network analysis revealed that, when compared to a random
sample, the primary hits of the genome-wide PQC siRNA assays
were significantly enriched in the category of protein translation (9
out of 84 hits, Fig. 5B). Amongst protein translation factors, we
identified 5 subunits of the 40S ribosome (RPS4X, RPS8, RPS13,
RPS24 and RPS28), NOP56/NOL5A, NH2PL1, and 2 subunits of
the translation initiation factor EIF3 (EIF3A and EIF3F; Figure 5B
and Table S8) as positive hits.
Hits were validated by independently transfecting the LTag(ts)-
EGFP and the LTag(WT)-EGFP cell lines with 4 distinct siRNA
oligos against 71 of the genes that scored positive in the primary
genome-wide screen (Fig. 5C, Table S9). In the LTag(ts)-EGFP cell
line, amongst 284 siRNA tested for validation, 45 had an EGFP/
DsRedExpress2 ratio of .140% of the negative control siRNA. We
considered genes that were targeted by at least two of these active
siRNAs as positive hits. As expected, the gene functions associated
with this group were mainly related to the Proteasome (PSMD1),
Ubiquitin (UBC), protein translation initiation (EIF3F) and the 40S
ribosome (RPS8, RPS13 and RPS28) (Figure 5C, Table S9).
Silencing of the translation initiation factor EIF3F leads to
misfolded protein stabilization
As observed when testing the UPS-focused library (Fig. 4A), most
validated hits also scored positive in the PQC assay when tested in
the LTag(WT)-EGFP/NLS-DsRedExpress2 expressing cell line,
indicating that they most likely participate in constitutive pathways
of protein degradation (Fig. 5C, Table S9). In contrast, silencing of
EIF3F, RPS8 and UBC with multiple independent siRNAs showed a
preferential increase in the EGFP/DsRedExpress2 ratio in the
LTag(ts)-EGFP expressing cell line when compared to the WT
counterpart (Figure 5C). This suggests that inhibition of translation
leads to the stabilization of misfolded proteins. In support, Western
blotting revealed that treatment of LTag(ts) expressing cells with the
translation inhibitor cycloheximide led to the stabilization of the
temperature-sensitive protein, but not of the WT protein at 38.5uC
(Figure S1E). This biochemical assay confirms the observations in
the dual fluorescent reporter and shows that inhibition of protein
translationperseissufficienttoinducethestabilizationofamisfolded
protein. Altogether, the genome-wide siRNA screen indicates
that modulation of translation initiation results in a preferential
stabilization of PQC protein substrates when compared to more
stable, properly folded proteins. This effect is mediated via the
translation initiation complex EIF3.
Discussion
Here we describe and use a high-content cell-based assay for the
discovery of human PQC factors involved in the degradation of
misfolded proteins. Fluorescent reporters for generic proteasome-
mediated protein degradation have been a useful tool to study the
activity of these pathways in cell culture [34], however, no assay
specifically dedicated to the discovery of mammalian PQC has
been available. Our approach to measure PQC activity in human
cells involves fusing EGFP to a temperature-sensitive version of the
SV40 virus Large T-antigen and measuring its degradation in
intact cells. We find that the temperature-sensitive SV40-LTag
reporter protein is efficiently degraded upon switching to the
restrictive temperature but is stable at the permissive temperature.
Degradation is not due to defective folding of EGFP at 38.5uC
because an identical fusion with the wild-type, stable version of the
substrate is not affected at this temperature. In contrast to other
temperature-sensitive proteins that have been used to measure the
activity of the PQC pathway in S.cerevisiae, and which are generally
short-lived proteins [12,35,36], the LTag(ts) has a long half-live in
vivo [37] with ,50% of LTag(ts) degraded within 12 hours after
switch to the non-permissive temperature (Figure S1A). As such,
our assay is well suited to probe the still poorly understood fate of
long-lived proteins that are often of particular relevance for
disease. Prominent examples include the nuclear lamins, which
accumulate at the nuclear periphery in the premature aging
disorder Hutchinson-Gilford Progeria Syndrome, or huntingtin, a
protein that can pathologically misfold in the nucleus [38]. A
further advantage of our assay compared to previous reporters of
protein degradation [34], is its ability to discriminate effects that
are unrelated to protein degradation based on monitoring levels of
the internal control NLS-DsRedExpress2. Measuring the EGFP/
DsRedExpress2 fluorescence ratio is a quantitative, reproducible
and robust way to measure the PQC activity in human cells.
By directly comparing the effects of the same siRNA treatment
on LTag(ts)-EGFP and LTag(WT)-EGFP, we were able to
distinguish genes that are generally involved in protein degrada-
tion, such as the ones encoding for proteasome subunits, from ones
that are preferentially involved in the acute response to LTag(ts)
misfolding at the restrictive temperature, such as the proteasome
chaperone POMP or the translation initiation factor EIF3F.
The results of an initial focused siRNA screen of ,1600 factors
involved in UPS strongly indicate that this assay system is capable
of capturing many of the factors that are essential for PQC. By
using the EGFP/DsRedExpress2 fluorescence ratio as a readout,
we identified 28 out of the 33 genes that encode for 26S
proteasome subunits among a total of 78 hits in our primary
screen, thus validating the rationale behind the design of the PQC
assay and demonstrating a low false negative discovery rate. In
addition, from a biological standpoint, the results of the PQC
screen described here clearly indicate that genes encoding 26S
proteasome subunits, ubiquitin, the 20S proteasome chaperone
POMP, and the E2 ubiquitin ligase UBE2D3, are the only ones
whose individual loss is sufficient to significantly inhibit degrada-
tion of the misfolded temperature sensitive protein. We cannot
entirely rule out the possibility that other such genes exist and that
they are not detected here due to incomplete siRNA gene
silencing, but we consider it unlikely given our high success rate in
identifying 26S proteasome subunits in our screen. The absence of
many ‘‘single hits’’ among known 26S proteasome-associated
Figure 2. The PQC assay quantitatively measures the degradation of LTag(ts)-EGFP at the restrictive temperature. a) U2OS cells stably
expressing LTag(ts)-EGFP and NLS-DsRedExpress2 (NLS-Red) were grown in 384 well-plates for 48 hrs at 33.5uC and then shifted at the indicated
temperatures for 24 hrs. DRAQ5 stains the DNA and is used to identify the nuclei. Cells were fixed in paraformaldehyde and imaged sequentially at
488 nm, 568 nm, and 640 nm (406magnification, 1 imaging field). Scale bar: 20 mm b) Montage of 12 406fields representing the entire population
of cells in a 384-well. Scale bar: 100 mm. c) Same as b), except that cells were treated with MG132 (250 nM). (-) indicates the untreated control. d)
Same as b) except that U2OS cells stably expressing the LTag(WT)-EGFP and NLS-DsRedExpress2 were used. e) Histograms representing the
quantification of nuclear fluorescence intensities and the EGFP/DsRedExpress2 ratio. Typically .300 cells were imaged per well. Values represent
averages +/2 S.E.M of 4 experiments.
doi:10.1371/journal.pone.0031684.g002
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pathways involved in the degradation of misfolded proteins. In the
future it will be interesting to test selected pair-wise combinations
of siRNA pools targeting independent genes to uncover genetic
compensatory interactions between pathways involved in PQC.
An unbiased genome-wide screen confirmed and extended the
findings obtained in the focused UPS screen. siRNA silencing of
the proteasome gene PSMD1, of the ubiquitin gene UBC and of
genes encoding subunits of the EIF3 translation initiation factor
and of the 40S Ribosome lead to the stabilization of the LTag(ts) at
38.5uC. By silencing the expression of one gene at a time, the
results of the genome-wide PQC screen thus suggests that in
human cells, beside cellular activities related to protein degrada-
tion, protein translation initiation is the other main non-redundant
pathway which, when inhibited, regulates the stability of unstable
or misfolded proteins. This is in line with previous findings in
lower eukaryotes, obtained by genome-wide siRNA screens for
modifiers of protein aggregation [19,21]. We find that the
genome-wide siRNA screen had a significantly lower validation
rate when compared to the UPS focused screen. This might be due
to the fact that the UPS library is pre-enriched in target genes
related to protein degradation thus increasing the hit rate. In
addition, due to the size of the genome-wide library, for logistical
reasons the genome-wide screen was run once as opposed to three
times for the smaller UPS screen. Furthermore, while validation of
the genome-wide screen was done using pools of RNAi
oligonucleotides of distinct chemistry from those used in the
primary screen, validation of the small scale screen was performed
by deconvolving the RNAi pools used in the in the primary
screening. Finally, compared to the UPS screen, the degree of
saturation was lower in the genome-wide screen allowing for the
possibility of affecting hit accuracy. Given the relatively strong
predominance of protein degradation and translation components
amongst the positive hits, it is likely that these additional factors
would fall into these functional classes as well.
In contrast to most identified factors, the 20S proteasome
chaperone POMP and the EIF3F subunit of the EIF3 translation
initiation complex had a differential effect on the stability of
LTag(ts)-EGFP. POMP was the first protein shown to assist in the
formation of the mature 20S proteasome [27], and it is considered
an essential factor during assembly of the 20S proteasome [30,33].
As such it is not surprising that it was identified in our primary
screen at 38.5uC as a PQC component. Contrary to our ex-
pectations, however, in contrast to other 26S proteasome subunits,
silencing of POMP did not have any significant effect at 33.5uC.
One possible explanation for this result is that increased POMP
activity is preferentially necessary in the presence of an increased
load of misfolded proteins, such as at 38.5uC. This is consistent
with the increased expression of POMP at the mRNA level during
proteotoxic chemical treatments, such as in response to MG132 or
IFN- c [29,30,39]. Alternatively, siRNA silencing of POMP might
only partially lower proteasome activity to levels that are sufficient
for the clearance of misfolded LTag(ts)-EGFP at the permissive
temperature, but these become limiting once the temperature is
increased and the pool of misfolded proteins increases in quantity.
In either case, these results identify POMP as a ‘‘single-hit’’ target
for the specific inhibition of the clearance of misfolded proteins
during conditions of enhanced proteotoxic stress. This finding is
possibly of relevance to cancer treatment since certain types of
tumours experience increased proteotoxic stress [40]. Hence, the
PQC assay described here might be a useful tool to identify
alternative targets for pharmacological inhibition of PQC
activities, beside the already known effect of 26S proteasome
and HSP90 inhibitors in the context of cancer treatment [41,42].
EIF3 is a multi-subunit protein complex that acts as platform to
bring together the 40S ribosome and several other translation
initiation factors to promote translation initiation [43]. The
identification of a component of the EIF3 complex as a specific
factor for degradation of misfolded proteins when compared to the
degradation of more stable substrates raises the intriguing
possibility that in mammalian cells the EIF3 translation initiation
complex might be important for coupling de novo protein synthesis
with a quality control step that eliminates misfolded polypeptides.
In support of a functional and physical link between EIF3 and
PQC, biochemical fractionation experiments in S.pombe revealed
the existence of a protein supercomplex containing ribosomes,
proteasomes, chaperones, EIF3 and other components of the
translation machinery [44]. Furthermore, in the same organism,
the eIF3e subunit is necessary for the nuclear localization of the
proteasome [44]. Possible interactions between the protein
translation and degradation machinery are also suggested by the
fact that the translation elongation factor EIF1A binds the
proteasome and promotes the destruction of newly synthetized
ubiquitinated proteins [45,46]. In addition, it is remarkable that an
estimated 30% of all the newly synthetized polypeptides are co-
translationally degraded in vivo, suggesting tight coupling of these
processes [47,48]. Alternatively, translation inhibition in mamma-
lian cells might lead to ubiquitin depletion and block proteasome
mediated protein degradation, as previously observed in S.cerevisiae
[49]. However, this is unlikely since ubiquitin has a significantly
longer half-life in mammalian cells and extended treatment of cells
with cycloheximide does not negatively affect proteasome function
[50–52]. Regardless of the details of the interplay between
translation inhibition, ubiquitin levels and PQC, the identification
of several translational components made possible by use of an
unbiased genome-wide screen in mammalian cells provides a first
hint for such coupling and lays the foundation for full elucidation
of these events in higher eukaryotes.
Materials and Methods
Cloning
pcDNA3-LTag(WT) was generated by cloning a PCR BamHI/
EcoRI fragment obtained from pBABE-neo LargeTc (Addgene
plasmid #1780) into pcDNA3 (Invitrogen) cut with the same
enzymes. pcDNA3-LTag(ts) expressing the tsa209 allele of LTag
Figure 3. Primary hits from the Ubiquitin Proteasome System (UPS) siRNA screen. a) U2OS cells expressing LTag(ts)-EGFP and NLS-
DsRedExpress2 were screened in triplicate at 38.5uC using a library containing 991 siRNA pools targeting human genes belonging to the Ubiquitin
Proteasome System (UPS). siRNA pools were ranked according to their Z-score in the EGFP/DsRedExpress2 ratio when compared to the median value
of the population. Positive control wells (red) were treated with MG132 (250 nM). The horizontal dashed line represents the threshold (Z=2) used for
the selection of the positive hits. b) U2OS cells expressing LTag(ts)-EGFP and NLS-DsRedExpress2 were treated with an siRNA pool against the PSMD8
subunit of the 19S proteasome, the 20S proteasome chaperone C13ORF12, or the 20S proteasome chaperone DSCR2/PAC1 for 48 hrs at 33.5uC and
then shifted to 38.5uC for 24 hrs. Images shown here are montages of 12 imaging fields at 406 magnification. Scale bar: 100 mm. c) Histogram
representing the Z-scores of the EGFP/DsRedExpress2 ratio obtained in the secondary screen at 38.5uC using a validation library containing 48 On-
Target Plus siRNA pools targeting selected primary hits from the UPS and Ubi123 screens. U2OS cells expressing LTag(ts)-EGFP and NLS-
DsRedExpress2 were used in this experiment. Typically .300 cells were imaged per well. Values represent averages +/2 S.E.M of 4 experiments.
doi:10.1371/journal.pone.0031684.g003
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31684Figure 4. PQC Validation of primary hits. a) U2OS cells expressing either LTag(WT)-EGFP or LTag(ts)-EGFP and NLS-DsRedExpress2 were
screened in quadruplicate at 33.5uC or 38.5uC using the validation library described in Figure 3C. The DZ-score is calculated as the difference between
the EGFP/DsRedExpress2 ratio Z-score obtained using LTag(ts)-EGFP cells and the EGFP/DsRedExpress2 ratio Z-score for LTag(WT)-EGFP expressing
cells. C13ORF12 is also known as POMP. b) Deconvolution and measurement by quantitative RT-PCR of the RNA silencing activity of the original
siGenome pool of 4 siRNA oligos targeting the POMP gene. c) Measurement of the biological activity of the 4 siRNA oligos directed against the POMP
gene in the PQC activity assay. Red bars represent siRNA oligos possessing siRNA silencing activity (see b)). Values represent averages +/2 S.E.M of 4
experiments.
doi:10.1371/journal.pone.0031684.g004
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change site-directed mutagenesis kit (Stratagene) using pcDNA3-
LTag(WT) as a template. The primers used were FW: CTG-
GCTGTTTAAAGGACTGATTGATAGTGGTAAAACTACA-
TTAGCAGCTGC, and RW:GCAGCTGCTAATGTAGTTT-
TACCACTATCAATCAGTCCTTTAAACAGCCAG. Retrovi-
ral vectors pQXCIN-LTag(WT) and pQXCIN-LTag(ts) were
generated by cloning a BamHI/BamHI fragment from pcDNA3-
LTag(WT) and pcDNA3-LTag(ts), respectively, into the bicistro-
nic vector pQCXIN (Clontech) cut with the same enzymes.
pQXCIN-LTag(WT)-EGFP and pQXCIN-LTag(ts)-EGFP were
generated in two rounds of PCR using either pQXCIN-LTag(WT)
or pQXCIN-LTag(ts), respectively, and pEGFPN1-HMGB1 [53]
as templates. In the first round, an N-terminal fragment containing
Figure 5. Genome-wide siRNA screen for PQC factors. a) U2OS cells expressing LTag(ts)-EGFP and NLS-DsRedExpress2 were screened against a
library containing ,18, 000 siRNA pools targeting human protein-coding genes. The histogram represents the distribution of the EGFP/
DsRedExpress2 ratio robust Z-score measured for each siRNA pool. The location of the EGFP/DsRedExpress2 ratio robust Z-score threshold used to
select positive siRNA pools is indicated. b) Analysis of hits from the genome-wide PQC screen reveals significant enrichment for translation/translation
initiation processes. Enrichment analysis was conducted using GeneGo Process Networks with a false discovery rate (FDR) of 0.05. 9 of the top 84
genes are found within this network, including EIF3A, EIF3F, NHP2-like protein 1 (NH2L1), NOP56/NOL5A, RPS13, RPS24, RPS28, RPS4X and RPS8. c)
U2OS cells expressing LTag(ts)-EGFP or LTag(WT)-EGFP and NLS-DsRedExpress2 were independently transfected for validation with 4 siRNAs
targeting 71 of the genes that were scored as positive in the primary PQC screen. Positive hits in this secondary screen were classified as genes whose
silencing by at least two independent oligo siRNAs had a EGFP/DsRedExpress2 ratio larger than 140% of the value obtained by transfection of a non-
targeting siRNA oligo. The table shows such positive genes in the LTag(ts)-EGFP or LTag(WT)-EGFP expressing cell lines, respectively.
doi:10.1371/journal.pone.0031684.g005
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CATGGATAAA, RW: AGAGCCTCCGCCTCCAGAGCCT-
CCGCCTCCTGATGTTTCAGGTTCAGGGG and a C-termi-
nal fragment containing EGFP ORF with primers FW: GG-
AGGCGGAGGCTCTGGAGGCGGAGGCTCTGTGAGCAA-
GGGCGAGGAGCTG, RW: GGAGGCGGAGGCTCTGGA-
GGCGGAGGCTCTGTGAGCAAGGGCGAGGAGCTG. The
PCR fragments were gel purified, denatured, annealed and used in
a second round of PCR using the external primers. The products
from the second round of PCR were digested with BamHI/EcoRI,
gel purified and cloned into pQCXIN cut with the same enzymes.
To generate pQXCIN-LTag(WT)-EGFP-IRES-NLSDsRedEx-
press2 and pQXCIN-LTag(ts)-EGFP-IRES-NLS-DsRedExpress2,
a BstI/XhoI PCR fragment containing DsRedExpress2 N-
terminally tagged with the nuclear localization signal from LTag
was amplified from pLVXDsRedExpress2 (A kind gift of B. Glick,
[54] using primers FW: CGGCCCACAACCATGGCTCCAAA-
GAAGAAGAGAAAGGTCGATAGCACTGAGAACGTCATC,
RW: GGCGGCCTCGAGCTACTGGAACAGGTGGTGGC.
The PCR product was cut with BstI/XhoI and cloned into either
pQXCIN-LTag(WT)-EGFP or pQXCIN-LTag(ts)-EGFP cut with
the same enzymes.
Cell Culture
U2OS (human osteosarcoma) cells were obtained from ATCC.
Unless otherwise specified, cells were grown in McCoy’s 5A
Medium (Invitrogen), 15% Fetal Bovine Serum, 100 U/ml
penicillin and 100 mg/ml streptomycin at 33.5uCi n5 %C O 2.
Polyclonal cell lines expressing the different LTag constructs were
generated by retroviral infection of U2OS cells as previously
described ([55]). Cells stably expressing untagged alleles of LTag
were selected in 500 mg/ml G418, whereas a polyclonal
population of U2OS cells concomitantly expressing LTag-EGFP
(Either WT or ts) and NLS-DsRedExpress2 were selected by
FACS. In order to trigger the degradation of the temperature
sensitive protein, cells were switched from 33.5uC to 38.5uC for
24 hrs. Except where otherwise specified, MG132 (Calbiochem)
was used at a final concentration of 250 nM for 24 hrs.
siRNA reagents
siGenome pools and OnTargetPlus pools of 4 siRNA oligos per
gene were purchased from Dharmacon. Cells were transfected
using Dharmafect1 (ThermoFisher Scientific). The four indepen-
dent oligos present in the original siGenome pool targeting
hUMP1 were ordered from Dharmacon. The Ubiquitin Protea-
some (UPS) library contains 991 genes involved in proteasome and
ubiquitin metabolism (Table S1). The Ubiquitin sets 1, 2 and 3
containing genes encoding for E1, E2 and E3 ubiquitin ligases
were purchased from Dharmacon (Table S3). Genes selected for
the secondary screens and the relative OnTargetPlus siRNA oligos
sequences are described in Table S5.
Western Blotting and antibodies
Total cell lysates were obtained by direct lysis of cells in 16
Laemmli Buffer [56]. Cell lysates were boiled at 95uC, run on a 4–
12% SDS-PAGE Bi-Tris NUPAGE gel (Invitrogen), transferred to
a PVDF membrane (Millipore) and probed with appropriate
primary antibodies and HRP-labelled secondary antibodies. The
Western blots were developed using an ECL kit from Amersham/
Pharmacia. The following antibodies were used: mouse monoclo-
nal anti-LTag (BD Pharmingen), mouse monoclonal anti-b-
Tubulin (Sigma), goat polyclonal anti-POMP (Protoassemblin,
St. Cruz, E-20).
POMP localization upon heat shock
U2OS cells were grown at 37.0uC in McCoy’s 5A Medium,
15% Fetal Bovine Serum, 100 U/ml penicillin and 100 mg/ml
streptomycin. 10 mM Hepes pH 7.4 was added to the medium
and cells were further incubated for 2 hrs at 42.0uC before fixation
in 4% paraformaldehyde in PBS. Indirect immunofluorescence
microscopy using goat polyclonal anti-POMP (Protoassemblin, St.
Cruz, E-20) was performed as previously described [57].
qRT PCR
qRT PCR was performed as previously described [57]. Primers
used for POMP real time PCR were FW: TTTGCCTA-
GTCATCCCCTTG, RW: CGGAGCAAATAGACCCTGAA.
Primers used for PSMB5 real time PCR were FW: TTTGCC-
TAGTCATCCCCTTG, RW: CGGAGCAAATAGACCCT-
GAA.
siRNA transfection of cells in a 384-well format
Cells were transfected in triplicate on independent days with
siRNA oligos at a final concentration of 50 nM in a reverse format
using a Janus automated liquid handler (Perkin-Elmer). First,
3.75 ml of OPTIMEM (Invitrogen) were transferred into each well
of an empty PE-Cell Carrier 384-well imaging plate (Perkin-
Elmer). Then, 1.25 mlo fa1mM siRNA stock in OPTIMEM were
added to the. Finally, 5 mL of diluted Dharmafect1 were added
onto the siRNA. Plates were incubated 20 min at RT and then
4000 cells/well were seeded in the plate in a 15 ml volume of
McCoy’s 5A Medium, 15% Fetal Bovine Serum, 100 U/ml
penicillin and 100 mg/ml streptomycin using a Multidrop Combi
automated dispenser (ThermoFisher Scientific). Cells were incu-
bated at 33.5uC for 48 hrs and then switched to 38.5uC for
another 24 hrs, or for a control plate, left at 33.5uC for the entire
duration of the experiment.
Automated imaging
All the fixation, washing and staining steps were performed
using a Biotek EL406 automated plate washer. Cells were first
fixed by adding 25 ml/well of 4% paraformaldehyde in PBS
directly into the culture medium and incubated for 5 min at RT.
Cells were then washed 36 in PBS and stained with DRAQ5
(Biostatus Limited) 1:5000 in PBS. The automated imaging steps
were performed using an Opera system (Perkin Elmer). 12
confocal 406 imaging fields were sequentially imaged using a
488/640 nm excitation laser (1
st acquisition) and then using a
568 nm excitation laser (2
nd acquisition). Images were analysed
using the Acapella software package (Perkin-Elmer). The Green/
Red ratio was calculated as the ratio between the average nuclear
intensity signal per well in the 488 nm channel and the average
nuclear signal per well at the 568 nm channel. Typically .300
cells were imaged per well.
Statistical analysis
Normalized Z-score values for the Green/Red ratio and the
siRNA rank were calculated using the CellHTS2 package [58].
siRNA pools with Z-Score.2 were then selected for secondary
validation.
Genome-wide Screening
Genome-wide screening was conducted using Dharmacon’s
siGENOME SMARTPool library (ThermoFisher Scientific). This
library targets <18,000 human genes with pools of 4 siRNAs
targeting each gene. Briefly, siRNA (0.8 pmol) was spotted to 384
well plates wells (Corning 3712) using a VPrep liquid handler
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(0.1 ml, Invitrogen) was then added in 20 ml of serum free media
(McCoy’s 5A). Transfection reagent and siRNA were complexed
for 45 minutes at RT before adding cells (1,500) to 20 mlo f
mixtures comprising 20 nM siRNA in media containing 15%
serum. Cells were incubated for 48 h at 33.5uC before switching to
38.5uC for an additional 24 h. Cells were then fixed by adding
40 ml of 4% paraformaldehyde in PBS and incubating for
10 minutes at rt. Cells were washed with PBS (40 ml62) and
stained with Hoechst 33342 (1 mg/ml).
Cells were imaged on an ImageXpress Micro automated
microscope (Molecular Devices). Images were acquired using a
46objective and appropriate exposure times for each wavelength.
Analysis was performed using MetaXpress software (version
3.1.0.65, Molecular Devices). For each well, the average
normalized intensities for both green and red wavelengths (derived
using the median green or red intensity value for cells transfected
with Dharmacon non-targeting negative control siRNA #5) were
used to calculate green/red ratios.
Supporting Information
Figure S1 a) U2OS cells stably expressing either a wild-type
(WT) or a temperature-sensitive (ts) allele of LTag were grown at
33.5uC for 48 hrs and then shifted to 38.5uC for the indicated
amount of time. Total cell lysates were probed in Western Blotting
with the indicated antibodies. b) Same as a), except that cells were
either treated with DMSO or the proteasome inhibitor MG132 at
a final concentration of 2 mM. c) Distribution of the single-cell
EGFP/DsRedExpress2 ratios in populations of U2OS cells
expressing either LTag(WT)-EGFP or LTag(ts)-EGFP and NLS-
DsRedExpress2. d) Indirect immunofluorescence images of U2OS
cells grown for two hours at 37.0uC (Control) or 42.0uC (Heat-
Shock), fixed in paraformaldehyde and stained with an antibody
against POMP. DAPI, 49,6 9-diamidino-2-phenylindole. Scale bar:
20 mm. U2OS cells stably expressing either a wild-type (WT) or a
temperature-sensitive (ts) allele of LTag were grown at 33.5uC for
48 hrs and then shifted to the indicated temperature for the
indicated amount of time. e) Same as a), except that cells were
treated either with DMSO or with the protein translation inhibitor
cycloheximide (50 mg/ml) for 24 hrs. Protein lysates of treated
cells were probed in Western Blotting with the indicated
antibodies.
(TIF)
Table S1 Sequences of the siGenome 991 siRNA pools
contained in the UPS library.
(XLSX)
Table S2 Results of the PQC screen at 38.5uC using the
siGenome UPS library and cells expressing LTag(ts)-EGFP and
NLS-DsRedExpress2. Z-scores for the EGFP/DsRedExpress2
ratio are shown. Pos: Positive control samples treated with
MG132 (250 nM). siRNA pools highlighted in blue represent
positive hits in the screen.
(XLSX)
Table S3 Sequences of the 600 siGenome siRNA pools
contained in the Ubiquitin E1, E2 and E3 ligases library (Ubi123).
(XLSX)
Table S4 Results of the PQC screen at 38.5uC using the
siGenome Ubi123 library and cells expressing LTag(ts)-EGFP and
NLS-DsRedExpress2. Z-scores for the EGFP/DsRedExpress2
ratio are shown. Pos: Positive control samples treated with
MG132 250 nM. siRNA pools highlighted in blue represent
positive hits in the screen.
(XLSX)
Table S5 Cell viability data for the UPS and the Ubi 123 screens
using cells expressing LTag(ts)-EGFP and NLS-DsRedExpress2 at
38.5uC, as measured by counts of nuclei present at the end of the
experiment.
(XLSX)
Table S6 Sequences of the 48 On-Target Plus siRNA pools
contained in the validation library.
(XLSX)
Table S7 Cell viability data for the secondary validation screens
using cells expressing LTag(ts)-EGFP and NLS-DsRedExpress2 at
33.5uC and 38.5uC, as measured by counts of nuclei present at the
end of the experiment.
(XLSX)
Table S8 List of positive hits (EGFP/DsRed Z-score.3, EGFP
Z-score.1) from the genome-wide PQC screen in LTag(ts)-EGFP
and NLS-DsRedExpress2 expressing cells at 38.5uC. Full results of
the genome-wide PQC screen are also shown.
(XLSX)
Table S9 Results of the validation screen in either LTag(ts)-
EGFP or LTag(WT)-EGFP and NLS-DsRedExpress2 expressing
cells at 38.5uC for 71 of the positive hits from the primary genome-
wide screen. siRNA pools highlighted in blue represent positive
hits in the primary screen. Positive genes were defined as those for
which silencing by at least 2 siRNA oligos resulted in a EGFP/
DsRed ratio of .140% of the negative siRNA control. A
conversion table that reflects the different gene symbol nomen-
clature adopted by the siRNA providers for the primary and
validation screen (Dharmacon and Qiagen, respectively) is also
provided. The asterisk indicates that SERPINA13 is a pseudogene.
For this reason SERPINA13 was not included in the final table
shown in Figure 5C).
(XLSX)
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